Objectives: To evaluate the current practice and the willingness to shorten the duration of antibiotic therapy among infection specialists.
Introduction
Using the shortest possible duration of antibiotic treatment is a key component of responsible antibiotic use, [1] [2] [3] with some studies suggesting that shortened durations can limit the emergence of bacterial resistance, [4] [5] [6] without compromising clinical outcomes. [7] [8] [9] [10] [11] [12] [13] [14] [15] Most antibiotic stewardship guidelines recommend that stewardship teams implement guidelines and strategies to promote the shortest effective duration of antibiotic therapy. 6, 16 No study has, however, explored the current practices of infection specialists, who are often members of an antibiotic stewardship team, regarding duration of antibiotic therapy.
The objective of our international cross-sectional survey was thus to describe current practices of infection specialists as well as their willingness to shorten the duration of antibiotic therapy. Our hypothesis was that not all of them are ready to advise short durations and V C The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
this could be a barrier to implementation of guidelines and strategies promoting short durations of antibiotic therapy.
Methods

Study design
ESGAP (ESCMID Study Group for Antimicrobial stewardshiP) and SPILF (French Infectious Diseases Society) conducted a cross-sectional international Internet-based survey on duration of antibiotic treatments. Hospitalbased healthcare professionals (fully trained or in training) who were giving at least weekly advice to colleagues (outside their home department) on their antibiotic prescriptions could participate in this survey.
Survey instrument
The 25-item questionnaire was developed by a multidisciplinary group of experts in infectious diseases, microbiology and public health, based on a literature review (File S1, available as Supplementary data at JAC Online). 17 It was first pilot-tested among ESGAP and SPILF Executive Committee members to check for clarity and conciseness.
The questionnaire first collected information on respondents' characteristics (nine questions) and then comprised two parts: (A) the usual practice of respondents regarding recommendations they make to clinicians in their hospital or in primary care (outside their own department) regarding total durations of antibiotic treatment; and (B) the shortest total duration that they would be willing to recommend for the same cases. Parts A and B used the same 15 clinical vignettes, each one describing a specific disease, assuming for each a 'best case scenario', i.e. that an appropriate antibiotic was prescribed (in terms of choice of molecule, dose and interval of administration) and that the outcome was favourable under this treatment. The participants were only informed that the survey was about duration of antibiotic treatments and so they were not aware whilst completing part A on usual practices that they would subsequently be asked in part B about willingness to shorten durations. Macheda et al.
Survey distribution
The survey used the SurveyMonkey V R platform and stayed open from September 2016 to December 2016, with one reminder sent in November. It was advertised using the ESCMID Newsletter, as well as ESGAP and SPILF networks. Participation was voluntary, anonymous and without any compensation. According to regulations, ethics approval was not required.
Statistical analysis
Respondents' demographic and professional characteristics were first described as numbers and percentages. For each clinical vignette, the usual recommended duration of antibiotic therapy as well as the shortest duration that respondents were willing to recommend were presented as medians (in days). These last results were also presented by country for the countries with more than 10 respondents.
For each of the 15 vignettes, short treatment durations were defined based on a literature review 17 and a consensus among all authors (File S2).
Demographic and professional characteristics associated with (i) recommending short durations in more than 50% of the vignettes and (ii) the willingness to shorten treatment durations (durations recommended in part B of the questionnaire compared with those recommended in part A) in more than 50% of the vignettes were identified by using bivariate and multivariable logistic regression models. Respondents with missing data for 8 or more of the 15 clinical vignettes were not considered in these analyses. As our work was exploratory, since no risk factor associated with short durations of antibiotic therapy was available in the literature, we decided a priori that all eight individual characteristics would be entered in these models, except the country. Variables reaching a threshold of P , 0.20 in bivariate analyses were then entered in the multivariable model, with P , 0.05 being considered significant using two-sided tests. Statistical analyses were performed using SAS V R version 9.4 (SAS V R Institute, Inc., Cary, NC, USA).
Results
Sample characteristics
Of the 1053 people who responded to the survey, 136 were not eligible because they gave advice less than once a week on antibiotics and 51 were excluded because they did not answer the clinical vignettes. We included 866 participants from 
Usual practice and shortest durations
The participants' usual recommendations they make to clinicians regarding durations of antibiotic treatment and the shortest durations they would be willing to recommend for the same 15 clinical vignettes are presented in Table 2 . Table S1 presents for each vignette the percentage of respondents who were willing to choose a shorter duration (in part B of the questionnaire compared with part A) and shows that this ranged from 33.3% (220/661) for the Staphylococcus aureus bacteraemia vignette to 62.7% (402/641) for the erysipelas one.
Factors associated with short treatment duration
Overall, 86.5% (749/866) of respondents were eligible for the study factors associated with usual short treatment duration. Among these respondents, 36.2% (271/749) recommended a short duration in more than 50% of the vignettes and 4.1% (31/749) recommended a short duration in more than 75% of the vignettes.
Among all answers (749 respondents replying to 8-15 vignettes), short durations of antibiotic therapy were recommended in 42.7% (3838/8988) of cases. Table 3 presents the factors associated with a participant recommending a short duration in more than 50% of the vignettes. In multivariable analysis, being a man (aOR " 1.6, P " 0.002), a clinical pharmacist (aOR " 2.0, P " 0.039) and having fixed durations of antibiotic treatment in regional/ national guidelines (aOR " 1.5, P " 0.02) were all independently associated with such behaviour. Macheda et al.
Factors associated with the willingness to shorten treatment duration
Overall, 76.4% (662/866) of respondents were eligible for the study factors associated with the willingness to shorten treatment duration. Among them, 47.1% (312/662) were willing to shorten treatment duration for at least 50% of the clinical vignettes. Table 4 presents the factors associated with shortened durations in part B of the questionnaire (compared with part A) in more than 50% of the vignettes. In multivariable analysis, being a man (aOR " 1.7, P " 0.002) or an infectious diseases specialist (aOR versus clinical pharmacists " 3.3, P " 0.007) was independently associated with such behaviour.
Results by country
We received 10 or more responses from 27.6% (16/58) of the participating countries. Table 5 shows the wide variations between these countries in terms of the proportion of treatments that are usually recommended to be short and in willingness to shorten durations.
Discussion
Our large survey included 866 infection specialists, mostly (82%) clinical microbiologists or infectious diseases specialists, members of an antibiotic stewardship team in 73% of the cases, coming from all continents. More than a third of participants already frequently advised short durations of antibiotic therapy to prescribers and almost half of the participants were willing to shorten durations.
Twenty-two percent of the participants stated that their regional/national guidelines expressed durations of antibiotic therapy for a specific clinical situation as a fixed duration (e.g. 5 days), as opposed to a range (e.g. 5-10 days), and this was associated with usually recommending short durations in multivariable analysis. If a range is used, it is possible that prescribers feel more comfortable choosing a value in the middle of the range, or the longest duration, even if the intention of the range is to suggest that the shortest duration would be adequate for most patients. Based on our results, we suggest exploring the impact of fixed durations of antibiotic treatment in guidelines.
It is encouraging that almost half of the participants were ready to shorten durations of treatment, as it suggests that these infection specialists, who are frequently antibiotic stewards, are ready to promote strategies aimed at reducing duration of antibiotic therapy. Nevertheless, our results also show that the rest of the participants, who represent the majority, should be the target of specific educational and awareness initiatives, if they are to act as leaders and role models to promote such a strategy. This is important considering that only a third of respondents already advise short durations. Furthermore, being an antibiotic stewardship team member was not associated with short/shortening durations and this was quite unexpected since these are the people who should be most aware of current evidence. Issuing specific evidence-based guidelines at the national level is probably useful as a first step, as was done by the French Infectious Diseases Society. 17 Implementing interventions targeting as a priority the most frequent and/or non-severe infections could then lead to a large reduction in total antibiotic use. Country-specific barriers should be taken into account, as suggested by the large variations between countries we observed.
Our large survey presents original findings, but has some limitations. The majority (58%) of respondents came from university public hospitals and most respondents (73%) were members of an antibiotic stewardship team, limiting the generalizability to the general infection specialists' community; moreover, around half of the responses came from four countries (France, UK, Spain and Germany) and it is possible that the most motivated or knowledgeable infection specialists participated, which might limit the generalizability of our results. Although vignettes have been shown to be a valid tool for assessing healthcare professionals' practices, 18 responses do not necessarily reflect the daily practices of respondents.
Conclusions
Our survey shows that the majority of antibiotic stewards currently do not advise the shortest possible duration of antibiotic therapy to prescribers in many different clinical scenarios. However, half of them are willing to shorten those durations. Implementing a strategy to shorten antibiotic durations must first involve training antibiotic stewardship members, as well as studying the impact of fixed durations in guidelines.
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